浙江新和成股份有限公司2005年第一季度报告（节录）_医药资讯

财务资料1、主要会计数据及财务指标单位：（人民币）元本报告期末上年度期末本报告期末比上年度期末增减（％）总资产1,818,968,394.381,597,005,026.4913.90股东权益（不含少数股东权益）744,587,990.88728,905,012.262.11每股净资产6.536.392.19调整后的每股净资产6.496.371.88报告期（1-3月）年初至报告期末本报告期比上年同期增减（％）经营活动产生的现金流量净额-72,920,069.34-72,920,069.34---每股收益0.140.14-22.22净资产收益率（％）2.112.11减少了2.28个百分点扣除非经常性损益后的净资产收益率（％）1.731.73减少了1.79个百分点非经常性损益项目金额（1-3月）投资收益---营业外收入410,735.49营业外支出-98,346.49补贴收入2,555,935.85小计2,868,324.85减：所得税影响数额57,310.90少数股东损益30,001.79非经常性损益净额2,781,012.162、利润表单位：（人民币）元项 目2005年1-3月2004年1-3月合并数母公司合并数母公司一、主营业务收入341,939,677.80323,492,520.48276,344,968.26273,269,206.41减：主营业务成本271,660,156.43260,982,508.80214,587,355.81218,259,081.35主营业务税金及附加96,185.320.00168,480.41二、主营业务利润70,183,336.0562,510,011.6861,589,132.0455,010,125.06加：其他业务利润3,071,710.013,218,647.761,632,930.911,535,699.58减：营业费用11,299,096.338,177,806.7410,179,171.637,593,025.48减：管理费用31,708,959.3228,214,862.4727,385,097.0224,811,566.29减：财务费用10,577,502.2510,167,183.168,745,794.858,370,017.28三、营业利润19,669,488.1619,168,807.0716,911,999.4515,771,215.59加：投资收益-931,541.68-2,907,268.02303,367.85-1,033,731.33补贴收入2,555,935.852,555,935.852,632,400.002,438,000.00营业外收入410,735.49266,276.291,003,591.291,001,276.29减：营业外支出557,910.83422,274.65939,402.47835,801.76四、利润总额21,146,706.9918,661,476.5419,911,956.1217,340,958.79减：所得税5,973,117.286,274,226.875,295,317.285,259,107.74少数股东收益-509,388.91-106,188.58五、净利润15,682,978.6212,387,249.6714,722,827.4212,081,851.05 详见《浙江新和成股份有限公司2005年第一季度报告》（“据深圳证券交易所”；医药网整理，严禁转载） 医药网新闻